'Hope' is never a great strategy. VET has struggled with growth, partly due to pricing but also execution. A few years ago management promised no changes to the dividend and then cut it. It is still in the penalty box for that. The stock is more expensive on valuation than many peers, still. Debt is higher than most at 3X cash flow. The sector has not been great and it has missed estimates in eight quarters in a row. On the plus side, there has been some insider buying and we have to think it is a merger or takeover target at some point. It has potential, but we would not see it as a must-own in the sector, at all.
5i Research Answer: